A group of nearly 60 health experts has proposed new definitions and diagnostic criteria for clinical obesity, aiming to revolutionize how this condition is identified and treated. The initiative seeks to equip clinicians with pragmatic tools to determine which patients stand to benefit most from targeted interventions. By specifying 18 symptoms for adults and 13 for children and adolescents, such as sleep apnea, high blood pressure, and knee pain, the commission aims to offer a more comprehensive understanding of obesity.
The commission highlights the inclusion of difficulties with everyday tasks, like bathing, as symptoms of clinical obesity. This nuanced approach marks a departure from the traditional reliance on Body Mass Index (BMI) as the primary diagnostic tool. While the World Health Organization (WHO) has classified obesity as a disease for over 75 years, the current standard defines adults with a BMI of 30 or above as having obesity. The recommended cutoff for BMI in Asians is slightly lower at 27.5. However, the commission suggests that two body metrics or a body composition scan could potentially replace BMI in future assessments.
Francesco Rubino, a leading voice in the commission, emphasizes the need for transformation in obesity diagnosis and treatment.
“We are calling for a change — a radical change,” – Francesco Rubino
This proposed shift seeks to address concerns over costly interventions like GLP-1 drugs, bariatric surgery, and lifestyle counseling, which pose financial challenges for patients, health systems, and insurers alike. By refining diagnostic criteria, clinicians could better identify patients requiring anything from simple monitoring to advanced weight-loss medications.
The introduction of "preclinical obesity" represents another innovative concept within this framework. This term describes individuals whose surplus body fat does not yet affect tissues or organs but may elevate their risk of developing clinical obesity in the future. Despite its potential advantages, some experts express skepticism regarding its acceptance among insurers.
“Preclinical obesity will struggle, I think, in terms of coverage by insurers.” – Fatima Cody Stanford
The proposed criteria have sparked interest due to longstanding criticisms of BMI as an isolated measure of obesity. Fatima Cody Stanford notes the openness to this new perspective among stakeholders.
“I think that there has been so much pushback at BMI by itself that people are ready to potentially entertain a new way of thinking.” – Fatima Cody Stanford
Nonetheless, the initiative faces scrutiny over potential implications for patient care. Francisco Lopez-Jimenez cautions against any reduction in attention or treatment for individuals under the new guidelines.
“If that would lead to less attention, if that would lead to less treatments for those individuals, I would have a problem with that.” – Francisco Lopez-Jimenez
Leave a Reply